Statistics for Inhibition of focal adhesion kinase with her-2 targeted antibody pertuzumab (Omnitarg®, 2C4) in breast cancer cells
Total visits
| views | |
|---|---|
| Inhibition of focal adhesion kinase with her-2 targeted antibody pertuzumab (Omnitarg®, 2C4) in breast cancer cells | 4 |
Total visits per month
| views | |
|---|---|
| June 2024 | 0 |
| July 2024 | 0 |
| August 2024 | 0 |
| September 2024 | 0 |
| October 2024 | 1 |
| November 2024 | 1 |
| December 2024 | 0 |
File Visits
| views | |
|---|---|
| Inhibition of focal adhesion kinase with her-2 targeted antibody pertuzumab (Omnitarg®, 2C4) in breast cancer cells.pdf | 21 |
Top country views
| views | |
|---|---|
| China | 1 |
| Russia | 1 |
| Turkey | 1 |
| United States | 1 |
Top city views
| views | |
|---|---|
| Boardman | 1 |
| Istanbul | 1 |
| Moscow | 1 |